Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application
Open Access
- 14 May 2013
- journal article
- Published by Springer Nature in Leukemia
- Vol. 27 (12) , 2397-2403
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- DangER: protein ovERload. Targeting protein degradation to treat myelomaHaematologica, 2012
- The Role of Atg Proteins in Autophagosome FormationAnnual Review of Cell and Developmental Biology, 2011
- Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: Crosstalk among proteasome, autophagy-lysosome and ER stressInternational Journal of Oncology, 2011
- Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces AutophagyCancer Research, 2009
- Effect of autophagy on multiple myeloma cell viabilityMolecular Cancer Therapeutics, 2009
- Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway SubstratesMolecular Cell, 2009
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cellsBlood, 2007
- Suppression of basal autophagy in neural cells causes neurodegenerative disease in miceNature, 2006
- HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated HuntingtinJournal of Biological Chemistry, 2005